Literature DB >> 16047648

Normalization of reversed bio-intact-PTH(1-84)/intact-PTH ratio after parathyroidectomy in a patient with severe secondary hyperparathyroidism.

M Tanaka1, K Itoh, K Matsushita, K Matsushita, H Fujii, M Fukagawa.   

Abstract

The conventional intact-PTH assay detects both (1-84)-PTH and C-terminal fragments. The newer PTH assays, bio-intact-PTH assay and whole-PTH assay, use an antibody that binds only if the first amino acid is present, making it specific for the complete molecule, (1-84)-PTH. Thus, the intact-PTH concentrations are theoretically higher than bio-intact-PTH concentrations, and the ratio of bio-intact-PTH/intact-PTH is usually less than 1. These findings are observed in normal subjects and patients with primary and secondary hyperparathyroidism. Here we present a hemodialysis patient with severe secondary hyperparathyroidism who was found to have abnormally higher plasma bio-intact-PTH concentrations than intact-PTH concentrations, and the abnormally high biointact-PTH/intact-PTH ratio improved after parathyroidectomy (PTx). The patient was a 67-year-old man on maintenance hemodialysis since 1995. Since 2003, he was found to have high plasma intact-PTH concentrations and two swollen parathyroid glands in the neck. PTx with forearm autograft was performed in October 2003. Before PTx, an abnormally high ratio of bio-intact-PTH/intact-PTH was detected (840 pg/ml/770 pg/ml, > 1), while the same ratio was improved to normal range (100 pg/ml/200 pg/ml, < 1). Recently, a few patients with parathyroid carcinoma have been found to have higher (1-84)-PTH concentrations than intact-PTH concentrations with abnormally high (1-84)-PTH/intact-PTH ratio. Moreover, a new molecular form of PTH distinct from (1-84)-PTH was detected in these patients. We speculate that the resected parathyroid gland in our patient might have produced a new molecular form of PTH that was less well detected by the conventional intact-PTH assay.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16047648     DOI: 10.5414/cnp64069

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  9 in total

Review 1.  Diseases of the parathyroid gland in chronic kidney disease.

Authors:  Hirotaka Komaba; Takatoshi Kakuta; Masafumi Fukagawa
Journal:  Clin Exp Nephrol       Date:  2011-08-06       Impact factor: 2.801

Review 2.  Lessons from second- and third-generation parathyroid hormone assays in primary hyperparathyroidism.

Authors:  J C Souberbielle; P Boudou; C Cormier
Journal:  J Endocrinol Invest       Date:  2008-05       Impact factor: 4.256

Review 3.  Regulation of parathyroid function in chronic kidney disease (CKD).

Authors:  Masafumi Fukagawa; Shohei Nakanishi; Hideki Fujii; Yasuhiro Hamada; Takaya Abe
Journal:  Clin Exp Nephrol       Date:  2006-09       Impact factor: 2.801

4.  Nontruncated amino-terminal parathyroid hormone overproduction in two patients with parathyroid carcinoma: a possible link to HRPT2 gene inactivation.

Authors:  Philippe Caron; William F Simonds; Jean-Christophe Maiza; Mishaela Rubin; Tom Cantor; Louise Rousseau; John P Bilezikian; Jean-Claude Souberbielle; Pierre D'Amour
Journal:  Clin Endocrinol (Oxf)       Date:  2011-06       Impact factor: 3.478

Review 5.  The kidney and bone metabolism: Nephrologists' point of view.

Authors:  Masafumi Fukagawa; Yasuhiro Hamada; Shohei Nakanishi; Motoko Tanaka
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

6.  Reversed whole PTH/intact PTH ratio as an indicator of marked parathyroid enlargement: five case studies and a literature review.

Authors:  Hirotaka Komaba; Yoko Takeda; Jeongsoo Shin; Reika Tanaka; Takatoshi Kakuta; Yoshihiro Tominaga; Masafumi Fukagawa
Journal:  NDT Plus       Date:  2008-08

7.  The whole-PTH/intact-PTH ratio is a useful predictor of severity of secondary hyperparathyroidism.

Authors:  Motoko Tanaka; Hirotaka Komaba; Kazuko Itoh; Kazunori Matsushita; Kazutaka Matshushita; Yasuhiro Hamada; Hideki Fujii; Masafumi Fukagawa
Journal:  NDT Plus       Date:  2008-08

Review 8.  Secondary and Tertiary Hyperparathyroidism in Chronic Kidney Disease: An Endocrine and Renal Perspective.

Authors:  Manju Chandran; Jiunn Wong
Journal:  Indian J Endocrinol Metab       Date:  2019 Jul-Aug

9.  Decreased expression of calcium-sensing receptor and parafibromin in secondary hyperparathyroidism with an abnormal whole PTH/intact PTH ratio.

Authors:  Shunsuke Yamada; Masanori Tokumoto; Masatomo Taniguchi; Hidehisa Kitada; Kazuhiko Tsuruya; Takanari Kitazono
Journal:  Clin Kidney J       Date:  2013-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.